Close Menu

NEW YORK (360Dx) – Clearbridge Health Limited said today that it has entered into an exclusive partnership with Hunan, China's Agen Medicine Laboratory Technology Company, under which it will provide the firm with its ClearCell FX1 System for circulating tumor cell enrichment, offer training and assistance in Agen's development of laboratory developed tests, and then market those tests in China.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.